Please assess the completion status of the following clinical trial:

Trial Title: The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 20-40 years;~* American Standards Association status I-II.~Exclusion Criteria:~* Patients with allergy or hypersensitivity to propofol, lipid emulsion, or granisetron;~* History of nausea or vomiting within 24h before cesarean delivery;~* History of gastrointestinal or psychiatric disease, motion sickness, smoking, postoperative nausea and vomiting;~* Morbid obesity;~* Consumption of drugs such as opioids, antiemetics , H2 antagonists, phenothiazines and/or corticosteroids within 24h before the study period;~* Any chronic medical or surgical disorders complicating the pregnancy;~* Conditions contraindicating regional anesthesia.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- propofol group (Type: EXPERIMENTAL): first dose 0.3mg/Kg propofol, then 1mg/Kg/hr micro-pump
- control group (Type: PLACEBO_COMPARATOR): first dose 0.03ml/Kg normal saline, then 0.1ml/Kg/hr micro-pump

Based on this trial design, predict the completion outcome and termination type (if applicable).